Paper38514865
Quality reporting of randomized controlled trials on SGLT2 inhibitors for heart failure: a comprehensive assessment.
Yang Y and 5 others. Sci Rep, 2024. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Quality reporting of randomized controlled trials on SGLT2 inhibitors for heart failure: a comprehensive assessment. Papers, record 38514865. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38514865
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Quality reporting of randomized controlled trials on SGLT2 inhibitors for heart failure: a comprehensive assessment.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sodium-Glucose Transporter 2 Inhibitors | Major topic |
| Heart Failure | Major topic |
| Humans | |
| Randomized Controlled Trials as Topic | |
| Reference Standards | |
| Sample Size |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29748368 | Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors. | Circ Res | 2018 | https://conductscience.org/library/papers/29748368 | PubMed |
| 2 | 29589183 | New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors. | Curr Diab Rep | 2018 | https://conductscience.org/library/papers/29589183 | PubMed |
| 3 | 20334633 | CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. | BMC Med | 2010 | https://conductscience.org/library/papers/20334633 | PubMed |
| 4 | 37653530 | Reporting quality of randomized controlled trials in prehabilitation: a scoping review. | Perioper Med (Lond) | 2023 | https://conductscience.org/library/papers/37653530 | PubMed |
| 5 | 8806314 | CONSORT. | Lancet | 1996 | https://conductscience.org/library/papers/8806314 | PubMed |
| 6 | 33121749 | Importance of proper conduct of clinical trials. | Br J Anaesth | 2021 | https://conductscience.org/library/papers/33121749 | PubMed |
| 7 | 29742449 | Quality improvement in randomized controlled trial abstracts in prosthodontics since the publication of CONSORT guideline for abstracts: a systematic review. | J Dent | 2018 | https://conductscience.org/library/papers/29742449 | PubMed |
| 8 | 11304107 | The revised CONSORT statement for reporting randomized trials: explanation and elaboration. | Ann Intern Med | 2001 | https://conductscience.org/library/papers/11304107 | PubMed |
| 9 | 15883903 | Understanding interobserver agreement: the kappa statistic. | Fam Med | 2005 | https://conductscience.org/library/papers/15883903 | PubMed |
| 10 | 36122823 | Use of statistical methods among acupuncture randomized controlled trials was far from satisfactory. | J Clin Epidemiol | 2022 | https://conductscience.org/library/papers/36122823 | PubMed |
| 11 | 33817962 | Adherence to the CONSORT statement and extension for nonpharmacological treatments in randomized controlled trials of bariatric surgery: A systematic survey. | Obes Rev | 2021 | https://conductscience.org/library/papers/33817962 | PubMed |
| 12 | 33858355 | A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data. | BMC Med Res Methodol | 2021 | https://conductscience.org/library/papers/33858355 | PubMed |
| 13 | 28586958 | Reporting Quality of Randomized, Controlled Trials Evaluating Combined Chemoradiotherapy in Nasopharyngeal Carcinoma. | Int J Radiat Oncol Biol Phys | 2017 | https://conductscience.org/library/papers/28586958 | PubMed |
| 14 | 36251569 | The reporting and methodological quality of split-mouth trials in oral implantology: A methodological study. | Clin Oral Implants Res | 2022 | https://conductscience.org/library/papers/36251569 | PubMed |
| 15 | 36254693 | Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. | Eur Heart J | 2023 | https://conductscience.org/library/papers/36254693 | PubMed |
| 16 | 32387277 | Integrity of randomized controlled trials: challenges and solutions. | Fertil Steril | 2020 | https://conductscience.org/library/papers/32387277 | PubMed |
| 17 | 34352811 | Assessing Research Misconduct in Randomized Controlled Trials. | Obstet Gynecol | 2021 | https://conductscience.org/library/papers/34352811 | PubMed |
| 18 | 28522450 | Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors). | Circulation | 2017 | https://conductscience.org/library/papers/28522450 | PubMed |
| 19 | 29916205 | Randomised controlled trials - the gold standard for effectiveness research: Study design: randomised controlled trials. | BJOG | 2018 | https://conductscience.org/library/papers/29916205 | PubMed |
| 20 | 16948622 | Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. | Med J Aust | 2006 | https://conductscience.org/library/papers/16948622 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38514865
GET https://conductscience.org/api/papers/v1/38514865/references?page=2